April 21, 2023

Advanced Research Projects Agency for Health (ARPA-H) Open-Office Broad Agency Announcement (BAA)

The Advanced Research Projects Agency for Health (ARPA-H) has issued an Open Office Broad Agency Announcement (BAA). ARPA-H’s mission is to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society's most challenging health problems.

Awardees will develop groundbreaking new ways to tackle health-related challenges through high-potential, high-impact biomedical and health research. With a scope spanning the molecular to the societal, ARPA-H seeks proposals that aim to rapidly achieve better health outcomes across patient populations, communities, diseases, and health conditions, including in support of the Cancer Moonshot. 

Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, or systems. The four initial focus areas are:

(1) Health Science Futures;

(2) Scalable Solutions;

(3) Proactive Health;

(4) Resilient Systems;

Please see the BAA and associated attachments for further details. This BAA will remain open until March 2024.

Oak Ridge Associated Universities (ORAU)

ORAU’s FY 2023 Innovation Partnerships Program (formerly Events Sponsorship Grant Program) has been restructured. The goal of this grant program change is to drive new opportunities for university consortium members and ORAU experts to formulate meaningful collaborations. Applications must be focused on one or more of the FY2023 ORAU core focus areas:

• Climate and Environment
• Health Equity
• Future of STEM Workforce

Innovation Partnership applications should focus on focused workshops/conferences that highlight your university’s strategic STEM research and education growth areas, and where collaborations with other member universities would add value.

ORAU is specifically interested in events that can bring more thought leadership in building a national strategy for STEM education and workforce development. 

Applications accepted anytime

Agency for Healthcare Research and Quality (AHRQ) Interest in Research on Climate Change and Healthcare

AHRQ has a special interest in receiving health services research grant applications that address the intersection of climate change and healthcare. Applications that address the following areas are of heightened interest:

• Reducing the healthcare sector’s greenhouse gas emissions and carbon footprint.
• Creating resilient healthcare systems and communities that can plan, prepare, respond, and adapt to climate-related threats.
• Addressing the inequitable impacts of climate change.

Climate change is the leading threat to public health, contributing to both individual health problems and broader disruptions to vital infrastructure and the healthcare system.

The healthcare industry is not only a responder to climate events, but a significant contributor to climate change through its emissions.

Research and action are needed on both fronts and must be guided by an equity lens that prioritizes protecting and empowering individuals and communities that face the highest risks and bear the highest burdens of environmental pollution and a changing climate.

Applications in these areas are being accepted through multiple programs. 

Deadline for applications vary based on program

Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites applications for the Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform initiative.

This Platform aims to transform the AD/ADRD research enterprise by serving as a central hub of research access that seeks to: 1) improve applicability and generalizability of findings through larger datasets that include more diverse populations; 2) capture more complete information through linking a variety of data sources; 3) increase the speed at which scientific questions can be answered; and 4) improve researchers’ ability to answer questions that cannot be feasibly or readily answered via clinical trial.

Deadline: 7/31/2023